Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder.

Soler, J.; Pascual, J.; Campins, Josefa; Barrachina, J.; Puigdemont, D.; Álvarez, E.; Pérez, V.

doi:10.1176/APPI.AJP.162.6.1221

Public

Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder.

Shared by NobleBlocks on Jun 1, 2005 • 12:00 AM UTC

Authors:

Soler J

Pascual JC

Campins J

Abstract

Objective The aim of this study was to determine the efficacy and safety of dialectical behavior therapy plus olanzapine compared with dialectical behavior therapy plus placebo in patients with borderline personality disorder.Method Sixty patients with borderline personality disorder were included i...

Discussions